Product Information
PAXIL 40 MG TABLET is a brand product labeled by Apotex Corp., priced at $11.5045 per EA under NDC 60505452003. Its NADAC has been published 95 times since Apr 17, 2024.
FDA first approved this application on Dec 29, 1992. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the paroxetine hydrochloride market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
40 mg/1
Manufacturer
Apotex Corp.NDC
60505452003
Classification
Brand
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
PAROXETINE HYDROCHLORIDEApproval Type
New Drug (NDA)
FDA Application
NDA020031FDA Approved
12/29/1992
TE Code
AB
On Market Since
3/11/2019
Pharmacological Classes
Price Statistics
The NADAC for PAXIL 40 MG TABLET has been published 95 times since Apr 17, 2024, and over the history we have for it it has risen 18.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $11.5045 per EA |
|---|---|
| All-time high | $11.6944 (Jul 15, 2026) |
| All-time low | $9.6843 (Aug 21, 2024) |
| 52-week high | $11.6944 |
| 52-week low | $10.0450 |
| Median price | $10.6428 |
| Average price | $10.5402 |
| Largest weekly change | +16.4% (Apr 22, 2026) |
| Weeks tracked | 95 |
| Tracking since | Apr 17, 2024 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 99% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of PAXIL 40 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for PAXIL 40 MG TABLET, manufactured by Apotex Corp., is $11.5045 per EA (NDC 60505452003), effective Aug 19, 2026.
How has the price of PAXIL 40 MG TABLET changed over time?
Over the history we have for it, the NADAC for PAXIL 40 MG TABLET has risen 18.8%. It has been tracked across 95 weekly CMS publications since Apr 17, 2024.
What are the highest and lowest recorded NADAC prices for PAXIL 40 MG TABLET?
Since Apr 17, 2024, the NADAC for PAXIL 40 MG TABLET has ranged from a low of $9.6843 (Aug 21, 2024) to a high of $11.6944 (Jul 15, 2026), with a median of $10.6428 per EA.
Are there cheaper alternatives to PAXIL 40 MG TABLET?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, PAROXETINE HCL 40 MG TABLET, is $0.0983 per EA — about 99% below PAXIL 40 MG TABLET.
Who manufactures PAXIL 40 MG TABLET?
PAXIL 40 MG TABLET (NDC 60505452003) is labeled by Apotex Corp., and CMS classifies it as a brand product.